CORRECTION: NeuroRx and Relief Announce Initial Successful Results from Expanded Access Use of RLF-100(TM) (aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% Survival Seen in ICU Patients

Correction of the press release published November 24, 2020: It has come to our attention that a mistake was printed

Read more

PCT Ltd. (PCTL) Received $400,000 in Financing for Expansion of Annihilyzer® Infection Control Systems and Other Products Amidst Increased COVID-19 Case Reports

LITTLE RIVER, S.C.–(BUSINESS WIRE)– PCT LTD (OTC Pink: PCTL) today announced that it has received $400,000 in funding from California

Read more

NuGenerex Immuno-Oncology Announces Closing of a Licensing & Distribution Agreement with Bintai Kinden to Advance the Clinical Development & Commercialization of Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Global Markets

Bintai Kinden Corporation Berhad (www.bintai.com.my), an investment holding company headquartered in Malaysia will fund the U.S. Clinical Trials for the

Read more

Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line

WAKEFIELD, Mass., July 20, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, reports today

Read more